Number of Shares and Voting Rights of Innate Pharma as of May 1, 2021

NEXT STORY
Tiziana Life Sciences Announces Initiation of Clinical Trial in a Secondary Progressive Multiple Sclerosis (SPMS) Patient with Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, Under an Individual Patient Expanded Access Program
PREV STORY
Burning Rock Reports First Quarter 2021 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech’s CEO to change – Erkki Pekkarinen appointed as a new CEO

FIT Biotech Oy Company release January 18, 2018 at 4.05 pm EET                          FIT Biotech's ...

author_avatar
NASDAQ Market News

Immutep Granted Chinese Patent For Eftilagimod Alpha In Chemo-Immunotherapy Combination

author_avatar
NASDAQ Market News